Newsfiscal.ai
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
· Published
Article summary
INmune Bio has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited to facilitate international access and distribution of its Ebstrocel™ therapy.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…